NCT06590714View on ClinicalTrials.gov

Perioperative Polmacoxib Reduce Opioid Consumption for Post Operative Pain After Rotator Cuff Tear.

NARecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

August 23, 2024

Primary Completion Date

August 22, 2025

Study Completion Date

August 31, 2025

Conditions
Rotator Cuff Tear
Interventions
DRUG

Experimental(Acelex cap m2mg)

"Experimental Arm (Polmacoxib (Acelex cap 2mg + NSAIDs-excluded non-opioid or opioid analgesics))~Polmacoxib (preventive Acelex cap 2mg) administered, dosage: 1 tablet orally once daily, regardless of meals.~NSAIDs-excluded non-opioid or opioid analgesics, dosage: as needed (PRN)."

DRUG

Active Comparator(NSAIDs-excluded non-opioid or opioid analgesics)

NSAIDs-excluded non-opioid or opioid analgesics, dosage: as needed (PRN).

Trial Locations (1)

11759

RECRUITING

Uijeongbu Eulji Medical Center, Eulji University, Uijeongbu-si

All Listed Sponsors
collaborator

Dong-A ST Co., Ltd.

INDUSTRY

collaborator

Seoul National University Hospital

OTHER

lead

Eulji University Hospital

OTHER